Product Pipeline

ImmunSYS™ is dedicated to developing therapeutics for several types of cancer.

In addition to prostate cancer, ImmunSYS™ is developing the platform MyVaccx™ technology for several other types of cancer. Our pipeline includes five proprietary, highly novel product candidates currently in clinical development. Our technology has a unique mechanism of action, and we believe that it could yield important therapeutic advances and differentiation from existing cancer therapies.